U.S. Infrastructure Stock News

NYSE:RBRK
NYSE:RBRKSoftware

Rubrik (RBRK) Is Down 7.9% After Analysts Trim Earnings Forecasts Into Stronger Quarter - What's Changed

Earlier expectations for Rubrik’s now-reported quarter called for earnings of US$0.04 per share and revenue of US$396.41 million, both materially higher than the same period a year ago. An interesting angle is that, even with these higher forecasts, analysts had trimmed their consensus earnings estimate for the quarter by 1.9% in the month before the report. We’ll now explore how anticipated double-digit revenue growth in that quarter may influence Rubrik’s existing investment narrative and...
NYSE:IT
NYSE:ITIT

Following Earnings Beats And Higher Outlook, Is Gartner (IT) Now Fully Valued?

Gartner (IT) is back in focus after a period of consistent revenue growth, repeated earnings beats, a higher company outlook, and expanded share repurchase plans that together appear to be supporting recent share price gains. Over the past month, Gartner’s share price has climbed 39.35%, adding to a 22.39% gain over 90 days. However, the year-to-date share price return is down 17.40% and the 1-year total shareholder return is down 19.47%, which signals recent momentum against a weaker...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs (CROX) Draws Fresh Analyst Support, Is The Stock Still A Bargain?

Analyst sentiment shift puts Crocs stock in focus Fresh analyst sentiment has pushed Crocs (CROX) into the spotlight after Zacks assigned the footwear company a Rank #2 and raised full year earnings estimates by 2.1% in the past quarter. The Crocs share price has cooled in the past month, with a 1-day share price return of 2.34% lower and a 30-day share price return of 8.78% lower. However, the year-to-date share price return is up 41.33% and the 1-year total shareholder return is 43.78%,...
NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO) And The Electrification Story On A Fair Value Debate

Helios Technologies (HLIO) has drawn investor attention after recent trading left the stock around $74.27, with returns over the past month and past 3 months both showing declines, while the year to date performance has been stronger. Over the past year, Helios Technologies has delivered a 37.91% total shareholder return, while more recent 30- and 90-day share price returns of 6.96% and 9.98% indicate fading momentum from earlier gains. Compare Helios Technologies with a hand picked list of...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Stock Still Looks Below Fair Value With Cash Flow And Earnings Aligned

Salesforce stock has risen sharply over the past month, yet both a Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks still point to the shares trading below what those models suggest as fair. That combination of a recent rebound and an undervalued signal is drawing attention as investors weigh how much of the story is already reflected in the price. The stock is up 25.7% over the past month, which has quickly reversed part of the longer term share price decline...
NYSE:JLL
NYSE:JLLReal Estate

Why Jones Lang LaSalle (JLL) Is Up 5.9% After Record Boston Office Sale And Earnings Upgrade

Earlier in 2026, Jones Lang LaSalle’s Capital Markets group completed the US$435,000,000 sale of One Marina Park Drive, a 494,938-square-foot Tier 1 office tower in Boston’s Seaport District, representing the largest pure-office transaction in the city in five years and signaling renewed institutional interest in premium assets. This landmark deal, together with upward earnings estimate revisions and a Zacks Rank upgrade, points to improving business fundamentals and stronger institutional...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

West Pharmaceutical Services (WST) is back in focus after recent share price swings, with the stock closing at US$348.48. Investors are weighing this move against its performance over the past month and the past three months. Over a longer stretch, West Pharmaceutical Services has seen a strong year-to-date share price return of 26.08%, alongside a 1-year total shareholder return of 42.97%. However, the 3-year and 5-year total shareholder returns show declines, which suggests that momentum...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Why Nebius Group (NBIS) Is Down 10.7% After Massive Convertible Debt Raise To Fund AI Expansion

Nebius Group N.V. recently completed a very large private offering of convertible senior notes, raising about US$5.75 billion through new 0.50% 2030 and 4.5% 2034 senior unsecured, callable, Eurodollar and Eurobond issues under Rule 144A, alongside exchanging US$800 million of existing convertible notes for roughly 15.8 million Class A shares. The company plans to channel this expanded funding into AI-focused data center and cloud infrastructure buildouts, amplifying both its growth...
NYSE:ESS
NYSE:ESSResidential REITs

Does Slowing New Supply and Firm Occupancy Change The Bull Case For Essex Property Trust (ESS)?

In recent months, Essex Property Trust has benefited from slowing apartment development, strong occupancy, and high resident retention across its core West Coast markets, supporting more stable rental income despite some pockets of excess supply and weak new-lease pricing. An interesting angle for investors is how limited new housing supply in these technology-driven, supply-constrained regions is reinforcing Essex’s ability to keep properties well leased and maintain consistent cash flows,...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line Holdings (NCLH) Modernization Push Puts Its Undervalued Narrative To The Test

Norwegian Cruise Line Holdings (NCLH) is in the middle of a large fleet modernization push, highlighted by the reveal of Norwegian Aura’s wellness-focused spa spaces and expanded dining concepts for its future flagship vessel. The unveiling of Norwegian Aura’s features comes after a weaker run for Norwegian Cruise Line Holdings’ stock, with a 30 day share price return down 10.89% and a year to date share price return down 24.23%. The 3 year total shareholder return of 2.07% contrasts with a 1...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

How Softer Net Interest Income Trends Could Reshape Texas Capital Bancshares’ (TCBI) Profitability Narrative

Recent commentary on Texas Capital Bancshares highlighted below-standard net interest income growth and difficulties finding attractive lending opportunities, adding to broader concerns about bank earnings and tighter regulation that have weighed on sentiment toward the sector. This combination of weaker core income trends and sector-wide regulatory and earnings pressures has sharpened investor focus on how effectively Texas Capital can convert its growth initiatives into durable...
NYSE:HPE
NYSE:HPETech

HPE (HPE) Stock May Still Trade At A Discount Despite A 298% Run

Hewlett Packard Enterprise stock has delivered very strong 5 year gains, yet the latest valuation checks send a mixed message as the Discounted Cash Flow (DCF) intrinsic value suggests undervaluation while market based multiples point to a richer price tag. For investors, the split between these methods makes the current level less straightforward to read. Hewlett Packard Enterprise has returned about 298.1% over the past 5 years, which puts extra focus on whether recent strength is fully...
NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics (GD) Faces A Pullback, Is It Still A Bargain?

General Dynamics (GD) is back in focus after fresh share price data showed the stock closed at US$376.58 on 26 August 2026. Recent performance has been mixed, with short term weakness and stronger multi year returns. Over the past week the General Dynamics share price has fallen 4.3% and it is down 2.6% over the past month, while the 90 day share price return of 9.9% and five year total shareholder return of 108.8% indicate that longer term momentum has still been positive. Scan beyond...
NYSE:OFG
NYSE:OFGBanks

OFG Bancorp (OFG) Could Be 5% Undervalued On Strong Buy Rank Upgrade

OFG Bancorp (OFG) stock is drawing fresh attention after the company was added to the Zacks Rank #1 Strong Buy List. This follows a 6.5% increase in its current-year earnings estimate over the past month. OFG Bancorp shares trade at US$52.05 after a small pullback over the past week. The stock still shows strong momentum with a 14.2% 90 day share price return and a 26.9% year to date share price return, alongside a 150.5% five year total shareholder return that points to sustained interest as...
NasdaqCM:ALTI
NasdaqCM:ALTICapital Markets

First Internet Bancorp Stock And Other Cash Rate Plays Worth Watching

When long term rates rise and questions grow about the US “safe asset” premium, short duration cash and money market product providers move into sharper focus. These stocks sit where concerns about US$40tn of federal debt, higher real yields and refinancing risk intersect with investor demand for liquidity. This article walks through three stocks from our screener that appear particularly exposed to these shifting rate and funding currents. The three stocks below are just a starting sample,...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Is Astec Industries’ (ASTE) Softer Backlog Challenging the Core Earnings Narrative?

In recent months, Astec Industries has reported softer quarterly results and weaker backlog growth, prompting investors to question the strength of underlying demand. What stands out is that these demand concerns are emerging even as the company has previously shown solid momentum in both revenue and earnings per share. Next, we’ll examine how this softer backlog picture may affect Astec Industries’ previously outlined investment narrative and longer-term earnings assumptions. AI is about to...
NasdaqGM:CLYM
NasdaqGM:CLYMBiotechs

Should Climb Bio’s IgA Nephropathy Phase 2 Partnership Shift How CLYM Investors View Its Pipeline Strategy?

On August 13, 2026, Beijing Mabworks Biotech Co., Ltd. reported that the first patient with immunoglobulin A nephropathy had been dosed in a Phase 2 clinical trial in China, conducted in collaboration with Climb Bio, Inc. This milestone highlights Climb Bio’s increasing role in advancing immune-related therapies through international partnerships that can expand clinical and scientific reach. We will now examine how Climb Bio’s involvement in this Phase 2 immunoglobulin A nephropathy trial...
NYSE:ECVT
NYSE:ECVTChemicals

Ecovyst (ECVT) Names A New CFO, Is The Stock Cheap Or Pricey?

Ecovyst leadership change puts new spotlight on the stock Ecovyst (ECVT) is back on investor radars after appointing Laurie Bergman as Chief Financial Officer and Treasurer on August 24, 2026, succeeding long serving finance leader Michael Feehan. Set against a US$10.13 share price, Ecovyst has seen its 30 day share price return fall 18.7% and its 90 day move decline 27.44%, even though the year to date share price return is 2.22% and the 1 year total shareholder return sits at 10.47%. This...
NYSE:MC
NYSE:MCCapital Markets

What Moelis (MC)'s Hire of Restructuring Veteran Russell Mason Means For Shareholders

In August 2026, Moelis & Company appointed Russell Mason as a Managing Director in its Capital Structure Advisory Group in Dallas, bringing more than 20 years of experience in complex restructuring and distressed M&A from his prior role at Houlihan Lokey. This hire adds further depth to Moelis’s restructuring and creditor-side advisory capabilities, potentially strengthening its position in complex capital structure assignments. We’ll now examine how adding Russell Mason to the Capital...
NYSE:DAL
NYSE:DALAirlines

Delta Stock And 2 Airline Shares That Could Benefit From Lower Oil Prices

Oil prices have just slipped about 3% to 12 day lows, even as sanctions risks around Iran and possible secondary measures on China keep the longer term supply picture uncertain. That mix of cheaper crude today and unclear conditions ahead is pulling fresh attention to fuel sensitive businesses. In this article you will see three airlines from our Global Airline Operators with Fuel Cost Tailwinds screener that appear especially exposed to this news backdrop. The three airlines highlighted...
NYSE:ZTO
NYSE:ZTOLogistics

ZTO Express (ZTO) Uses Buybacks Over Dividends After Strong Half-Year Results and Higher Volume Outlook

ZTO Express (Cayman) Inc. reported past half-year 2026 results showing sales of CNY 27,832.26 million and net income of CNY 5,169.22 million, alongside continued share buybacks and the decision not to declare an interim dividend. The company also updated its 2026 parcel volume outlook to an expected 6.0%–10.0% year-on-year increase, highlighting management’s focus on scaling operations while returning capital through buybacks instead of interim cash dividends. We’ll now examine how ZTO’s...